Multicenter Bone and Joint Health Study
MOST
Multicenter Osteoarthritis Study (MOST) Second Renewal
1 other identifier
observational
4,185
1 country
3
Brief Summary
The purpose of this study is to investigate opportunities for prevention and treatment of knee osteoarthritis (OA) by evaluating potentially modifiable risk factors for disease and poor pain and physical function outcomes especially among those with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage and to limit the impact of disease once it has occurred.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2003
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
December 1, 2016
CompletedFirst Posted
Study publicly available on registry
January 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedFebruary 16, 2021
February 1, 2021
17.9 years
December 1, 2016
February 12, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Worsening knee pain
Worsening knee pain defined as reaching minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain questionnaire
Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)
Incident cartilage loss on MRI
Incidence of cartilage loss on MRI extending to the bone
Change from baseline (144-month) at 168-month follow-up contact
Function loss
Defined as minimally clinically important difference (MCID) for worsening on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function questionnaire
Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)
Secondary Outcomes (5)
Onset of constant knee pain
Change from baseline (144-month) at ≥2 follow-up contacts (152-, 160-, 168-month follow-up contacts)
Worsening on MRI
Change from baseline (144-month) at 168-month follow-up contact
Worsening on X-ray
Change from baseline (144-month) at 168-month follow-up contact
New onset knee buckling
Change from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)
New repeated falls
Change from baseline (144-month) at ≥1 follow-up contact (152-, 160-, 168-month follow-up contacts)
Study Arms (1)
Early or mild knee symptoms
Existing Cohort study participants (3,026) were enrolled in 2003-2005, Surviving participants without endstage knee osteoarthritis will be asked to participate in the 144-, 152-, 160- and 168-month follow-up contacts \[2,660 were enrolled\]. New Cohort study participants (1,500) will be recruited and enrolled in 2016-2018 \[1,525 were enrolled\].
Eligibility Criteria
The purpose of this study is to investigate opportunities for prevention and treatment of knee osteoarthritis by evaluating potentially modifiable risk factors for disease and poor pain and physical function outcomes especially among those with early or mild knee symptoms. The goal of the study is to find novel strategies to prevent disease at an early stage and to limit the impact of disease once it has occurred.
You may qualify if:
- Age 45 to 69 Years (Adult, Senior)
- Males and Females
- Healthy Volunteers
- Community-based Sample
You may not qualify if:
- Rheumatoid or inflammatory arthritis (based on self-report and use of medications specific to these conditions)
- Serious health condition e.g., end-stage renal disease, etc. that would likely limit follow-up to less than 2-3 years
- Plan to relocate out of geographic region in next 3 years
- Not able to walk without the aid of a person or assistive device
- Knee joint replacement surgery in either knee
- Neither knee fits in the MRI knee coil (determined during Screening Visit).
- Not competent to give informed consent
- Advanced structural tibiofemoral or patellofemoral knee OA disease (KL grade 3 or 4) in either knee (Determined by Knee X-ray Screening)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- University of Iowacollaborator
- University of Alabama at Birminghamcollaborator
- Boston Universitycollaborator
- National Institute on Aging (NIA)collaborator
Study Sites (3)
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
University of Iowa
Iowa City, Iowa, 52240, United States
Boston University School of Medicine
Boston, Massachusetts, 02118, United States
Related Publications (1)
Rabe KG, Stockman TJ, Kern AM, Wirth W, Eckstein F, Sharma L, Lynch JA, Nevitt MC, Anderson DD, Segal NA. Longitudinal Relationship Between Tibiofemoral Contact Stress at Baseline and Worsening of Knee Pain Over 84 Months in the Multicenter Osteoarthritis Study. Am J Phys Med Rehabil. 2022 Aug 1;101(8):726-732. doi: 10.1097/PHM.0000000000001899. Epub 2021 Oct 8.
PMID: 34620738DERIVED
Biospecimen
Existing Cohort biospecimens were collected at enrollment, 30-month and 60-month follow-up. New Cohort biospecimens will be collected at 144-month which will be their enrollment visit).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Nevitt, PhD
University of California, San Francisco
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2016
First Posted
January 26, 2017
Study Start
January 1, 2003
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
February 16, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Access Criteria
- See NIA Biobank website
Anonymized clinical data will be shared via The NIA Biobank (https://agingresearchbiobank.nia.nih.gov/). MOST Existing Cohort data from previous grant cycles will be available in mid 2021. For more information visit MOST Online (https://most.ucsf.edu).